Company Search:
Advanced Search
Sponsored Links
Eurocine Vaccines AB Company Snapshot
Eurocine Vaccines AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eurocine Vaccines AB with three other companies in this sector in Sweden: Xbrane Biopharma Ab (2015 sales of 392,859.00 Swedish Kronor [US$47,814.87 ] ), Xintela AB (757,000.00 Swedish Kronor [US$92,134.47 ] ), and Biovica International AB (458,674.00 Swedish Kronor [US$55,825.21 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eurocine Vaccines AB
  Stock Performance Chart for Eurocine Vaccines AB
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 3.84
(Figures in Swedish Kronor)
1 Week -5.7%   13 Weeks -9.9%  
4 Weeks -17.8%   52 Weeks 245.9%  
Eurocine Vaccines AB Key Data:
  Ticker: EUCI Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 550,000
(Year Ending Jan 2016).
Employees: 3
  Currency: Swedish Kronor Market Cap: 205,281,489
  Fiscal Yr Ends: June Shares Outstanding: 53,458,721
  Share Type: Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.